This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Myriad Genetics, Inc.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: The Innovations of Dennis G. Ballinger
Introduction
Dennis G. Ballinger is a notable inventor based in Menlo Park, California. He is recognized for his contributions to the field of genetics, particularly in relation to coronary heart disease. His work has significant implications for understanding and diagnosing metabolic disorders.
Latest Patents
Dennis G. Ballinger holds a patent for the Chromosome 11-linked coronary heart disease susceptibility gene CHD1. This patent focuses on the human coronary heart disease susceptibility gene (CHD1), with certain alleles linked to an increased risk of coronary heart disease. His research delves into germline mutations in the CHD1 gene and their potential use in diagnosing predispositions to coronary heart disease and various metabolic disorders. These disorders include hypoalphalipoproteinemia, familial combined hyperlipidemia, insulin-resistant syndrome X, obesity, diabetes, and dyslipidemic hypertension. Furthermore, he explores presymptomatic therapies for individuals carrying deleterious alleles of the CHD1 gene, which may involve gene therapy, protein replacement therapy, and the administration of protein mimetics and inhibitors. His work also includes the screening of drugs for dyslipidemic therapy.
Career Highlights
Throughout his career, Dennis has worked with prominent companies in the biotechnology sector, including Myriad Genetics, Inc. and MGI Tech Co., Ltd. His expertise in genetics and metabolic disorders has positioned him as a valuable contributor to advancements in medical research.
Collaborations
Dennis G. Ballinger has collaborated with notable professionals in his field, including Wei Ding and Susanne Wagner. These collaborations have further enriched his research and innovations.
Conclusion
Dennis G. Ballinger's work in genetics, particularly regarding coronary heart disease, showcases his innovative spirit and dedication to improving health outcomes. His contributions continue to influence the understanding and treatment of metabolic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile